Independent forecasts built on public federal data. Not a U.S. government website.

Midazolam Injection CIV, 10mg/0.7mL Auto-injector

SPE2DP-25-R-0007 · DEPT OF DEFENSE

A MEDICINAL AND BOTANICAL MANUFACTURING solicitation, performed in Philadelphia, PA, with responses due 2025-10-12. AwardCast estimates what this specific solicitation will close for, before you bid.

SPE2DP-25-R-0007
solicitation
325411
NAICS
6505
PSC
NONE
set-aside
Philadelphia, PA
place
2025-10-12
responses due

What's being bought

Solicitation: SPE2DP-25-R-0007 Item: Midazolam Injection CIV, 10mg/0.7mL Auto-injector NSN: 6505-31-019-0519 Description: The Defense Logistics Agency Troop Support has a requirement for the supply of Midazolam Injection CIV, 10mg/0.7mL Auto-injector. The Midazolam Auto-injector shall be made in acc

Comparable recent awards in MEDICINAL AND BOTANICAL MANUFACTURING

WinnerAward valueOffersDate
ACCREDO HEALTH GROUP, INC$349K12026-06-30
GUMIX INTERNATIONAL, INC.$13K32026-06-02
ANIMAL HEALTH INTERNATIONAL, INC.$950Kn/a2026-05-22
AMERISOURCEBERGEN DRUG CORP$26Kn/a2026-04-05
AMERISOURCEBERGEN DRUG CORP$290Kn/a2026-04-05

Questions

What is solicitation SPE2DP-25-R-0007?

Midazolam Injection CIV, 10mg/0.7mL Auto-injector, issued by DEPT OF DEFENSE, under NAICS 325411 (MEDICINAL AND BOTANICAL MANUFACTURING), performed in Philadelphia, PA. Responses are due 2025-10-12.

What do similar contracts close for?

Comparable closed awards in this category ran from $13K to $950K, across 5 awards shown above. Those are historical results, not a forecast for this solicitation.

Is SPE2DP-25-R-0007 set aside?

NONE. Check the notice on SAM.gov for the eligibility language that governs.

Explore the market

Comparable awards in this market ran from $13K to $950K. Get the full set by email.

Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.

Every forecast is scored against the real award once it becomes public. See the track record.

Closed awards from public federal data, not the forecast. One email, no account.

Or get the forecast for this solicitation — $49, one report.